Source: Annual Congress 2010 - The lung in haematological disorders



Rating:

Share or cite this content

Citations should be made in the following way:
V. Poletti (Forli, Italy). Clinical reasoning in patients with pulmonary infiltrates and haematological malignancies. Annual Congress 2010 - The lung in haematological disorders

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning Source: Eur Respir J 2009; 33: 6-8 Year: 2009 Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Value of transbronchial lung biopsy in pulmonary infiltrates in patients with haematologic malignancies Source: Annual Congress 2008 - News from diagnostic bronchoscopy Year: 2008 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Pulmonary complications in patients with hematologic diseases Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Diagnostic surgical lung biopsy in hematologic patients with pulmonary complications Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Lung function and haematological changes in patients with sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 116s Year: 2007 Endoscopic diagnostics of bronchopulmonary changes in patients with malignant hematological diseases Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Respiratory manifestations in hospitalized patients with hematological malignancies Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases Year: 2015 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 BAL as a diagnostic tool in severe pneumonia in patients with hematological malignancies Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 Clinical features of COPD in patients with chronic pulmonary aspergillosis Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Is bronchoscopy essential for pulmonary infections in patients with haematological malignancies? Source: Breathe, 16 (4) 200268; 10.1183/20734735.0268-2020 Year: 2020 Manifestations of malignancies during the course of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Clinical manifestations of chronic pulmonary aspiration in children Source: Annual Congress 2008 - Diagnosis and management of chronic pulmonary aspiration in children Year: 2008 Diagnostic yield and safety of flexible bronchoscopy for the diagnosis of pulmonary infections in patients with and without haematological malignancies Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019